CYP2C19 and myalgic encephalomeyelitis/chronic fatigue syndrome: Moreover, our previous work had shown that the CYP2C19*2 heterozygous genotype *1/*2 was significantly more frequent (P = 0.05) in MCS cases, not only versus controls but also versus FM + CFS cases [24].